Board-certified rheumatologist and a physician with more than 35 years of experience in medicine, specializing in rheumatology and the management of inflammatory and degenerative joint disease. He holds an M.D. degree and has maintained longstanding clinical and academic involvement in the diagnosis and treatment of complex rheumatologic disorders. His expertise includes gout therapy and practice, spondyloarthropathies, rheumatoid arthritis, osteoarthritis, and related autoimmune and metabolic conditions affecting the musculoskeletal system. His work encompasses evaluation and longitudinal management of crystal-induced arthritis, inflammatory joint disease, axial and spondylitis, and degenerative arthritis, as well as complications arising from chronic rheumatologic illness.

He holds multiple board certifications in Rheumatology and Internal Medicine in both the United States and Canada, including certification by the American Board of Internal Medicine in Internal Medicine and Rheumatology, certification in Geriatric Medicine, and diplomate status with the Royal College of Physicians and Surgeons of Canada and related provincial medical authorities. He is also a Diplomate of the National Board of Medical Examiners.

In addition to clinical practice, he has had an extensive academic and research career with substantial federal research funding as principal investigator and co-investigator on multiple projects. He has received competitive fellowship and research awards, including international research fellowships and foundation-supported investigator awards. He has also delivered named and invited lectures nationally and internationally, reflecting recognized authority in rheumatology.

His professional leadership includes senior roles in national rheumatology guideline development initiatives focused on gout and crystal-associated diseases. He has contributed to the development and refinement of evidence-based treatment recommendations for inflammatory arthritis and related metabolic conditions. He has authored and edited multiple scholarly publications and reference works addressing gout and crystal arthropathies and has held editorial leadership positions with prominent peer-reviewed journals in the field of rheumatology.

He has more than 5 years of expert witness experience, providing consultation and expert analysis in matters involving diagnosis, treatment decisions, medication management, disease progression, and standard-of-care issues in patients with gout, rheumatoid arthritis, spondyloarthropathy, and osteoarthritis. His opinions are grounded in more than 35 years of clinical experience, peer-reviewed scholarship, competitive research funding, national guideline leadership, and adherence to established rheumatologic standards and evidence-based treatment frameworks.